BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12225729)

  • 41. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
    Sato H; Zhao ZQ; McGee DS; Williams MW; Hammon JW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):302-14. PubMed ID: 7543634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective effect of 17β-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system.
    Tanaka R; Tsutsui H; Kobuchi S; Sugiura T; Yamagata M; Ohkita M; Takaoka M; Yukimura T; Matsumura Y
    Eur J Pharmacol; 2012 May; 683(1-3):270-5. PubMed ID: 22426161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective?
    Adams JA; Wu D; Bassuk J; Arias J; Lozano H; Kurlansky P; Lamas GA
    Resuscitation; 2007 Sep; 74(3):516-25. PubMed ID: 17466432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
    Rivo J; Zeira E; Galun E; Matot I
    Anesthesiology; 2004 Nov; 101(5):1153-9. PubMed ID: 15505451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
    Woolfson RG; Patel VC; Neild GH; Yellon DM
    Circulation; 1995 Mar; 91(5):1545-51. PubMed ID: 7867197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
    Gao F; Gao E; Yue TL; Ohlstein EH; Lopez BL; Christopher TA; Ma XL
    Circulation; 2002 Mar; 105(12):1497-502. PubMed ID: 11914261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
    Pabla R; Curtis MJ
    J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
    Horimoto H; Saltman AE; Gaudette GR; Krukenkamp IB
    Ann Thorac Surg; 1999 Sep; 68(3):844-9. PubMed ID: 10509972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
    Pernow J; Wang QD
    Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardioprotective activity of endogenous and exogenous nitric oxide on ischaemia reperfusion injury in isolated guinea pig hearts.
    Masini E; Salvemini D; Ndisang JF; Gai P; Berni L; Moncini M; Bianchi S; Mannaioni PF
    Inflamm Res; 1999 Nov; 48(11):561-8. PubMed ID: 10598011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
    Das B; Sarkar C
    Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The inhibitory effect of raloxifene on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells is mediated through a ROS/p38 MAPK/CREB pathway to the up-regulation of heme oxygenase-1 independent of estrogen receptor.
    Lee SA; Kim EY; Jeon WK; Woo CH; Choe J; Han S; Kim BC
    Biochimie; 2011 Feb; 93(2):168-74. PubMed ID: 20888885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
    Takahama H; Minamino T; Hirata A; Ogai A; Asanuma H; Fujita M; Wakeno M; Tsukamoto O; Okada K; Komamura K; Takashima S; Shinozaki Y; Mori H; Mochizuki N; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):159-65. PubMed ID: 16775664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia.
    Weinbrenner C; Liu GS; Downey JM; Cohen MV
    Cardiovasc Res; 1998 Jun; 38(3):676-84. PubMed ID: 9747435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.